DRIO · DarioHealth Corp.

Track DRIO — free

$5.80 -0.66 (-10.22%) At close · Oct 5

Rebalance outlook locked

Market Cap

$61.64M

9.80M

Volume · Oct 5 26.14K Avg daily vol (3M) 24.65K

Up next

Latest filing: 10-Q

filed Aug 11, 2026

Q1 2026 earnings call transcript

call held Mar 31, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$21.00M

Trailing 12 months

Net income (TTM)

−$35.67M

Trailing 12 months

Revenue growth YoY

-3.6%

Year over year

Operating margin

-151.6%

Trailing 12 months

P / E (TTM)

1.1

Trailing earnings · reciprocal yield 89.9%

FCF yield

-41.3%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+276.5%

Year over year · more shares

Price change (1Y)

-62.6%

Trailing year

Short interest

0.8%

Latest settlement · 2.7 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Strong Sell

SellHoldBuy

Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 15.5 · calm Equity put/call 0.59

Technical

price trend

Strong Sell

50 / 200-day cross No cross

Price vs 200-day avg −31%

below

Price vs 50-day avg −18%

below

RSI (14) 34

neutral

MACD trend Negative

52-week position 0%

near low

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −20%

trailing

6-month return −23%

trailing

YTD return −49%

this year

Relative strength −35%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $7 › 200d $8 — 200d above 50d

Institutional flow Flat

0% holders QoQ · +2 funds added

Insider flow Accumulating

Net +$100.0K over 90 days · 0% sells

Short interest Rising

0.80% of float · ▲ +4.1% MoM · 2.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

21 holders — mid 3-yr range

Squeeze score 37

low risk · 0–100

Fundamentals

Fair

Revenue growth +43%

Y/Y

Gross margin 171%

contracting

EPS growth −18%

Y/Y

Free cash flow $-26.1M

Quant / Vol

risk profile

Very High

Volatility 83%

annualized · 1-yr

Max drawdown −66%

past year

ATR 7.7%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Dec 31, 2025

Non-GAAP operating loss reduction · 2026 Non-GAAP 30%

Guided vs delivered · last 1 settled

Full-year revenue full-year

guided $10M – $12M

guided $10M – $12M $20.51M Beat +86.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell

4 · 3 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−31% Bearish

Price vs 50-day avg

−18% Bearish

RSI (14)

34 Neutral

MACD trend

Negative Bearish

52-week position

0% Bearish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $7 › 200d $8 — 200d above 50d

Institutional flow Flat

0% holders QoQ · +2 funds added

Insider flow Accumulating

Net +$100.0K over 90 days · 0% sells

Short interest Rising

0.80% of float · ▲ +4.1% MoM · 2.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

21 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $6 Now $6 · 0% Range high $16

vs 200-day avg -31% vs 50-day avg -18%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
customers	181	quarter ended June 30, 2026 filing	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Health Information Services — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
DRIO DarioHealth Corp. this stock	$61.64M	-49.0%	+43.0%	—	0.8%
VEEV Veeva Systems Inc	$45.44B	+27.0%	+28.1%	45.9	3.1%
TEM Tempus AI, Inc.	$15.34B	+41.5%	+83.4%	—	15.6%
PMDIY Pro Medicus Ltd./ADR	$12.20B	-29.7%	—	—	0.0%
BTSG BrightSpring Health Services, Inc.	$11.02B	+65.6%	+28.2%	33.8	5.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

% held: 8.7%
Net QoQ: +14.1K sh
Top holder: Nantahala Capital Managem…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Rising

Shares short

78.2K

Days to cover: 2.7d
Change: +3.1K sh

View

Short Volume

Short vol %

20%

As of: Oct 5, 2026

Short Total

View

Fails to Deliver

FTD shares

48.2K

Value: $380.8K
As of: Jul 23, 2026

View

Off-Exchange

Off-exchange %

26.4%

Week of: Aug 31, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net buying

Net (90d)

+$100.0K

Buyers / Sellers: 1 / 0

Buyers Sellers

View

Financials

Revenue (FY)

$7.4M

Net income (FY): $-41.7M
EPS diluted: $10.12

View

Filings

SEC Filings

Latest

8-K

Filed: Sep 4, 2026
This year: 11

View

Exempt Offerings

Offering

$17.5M

Filed: Oct 7, 2025

View

Earnings & Events

Webcasts

Last webcast

Mar 31, 2026

View

Performance

	5D	20D	120D	MTD	YTD
DRIO	-13.6%	-19.9%	-23.3%	-12.4%	-49.0%
SPY	+1.2%	+0.6%	+11.6%	+1.6%	+13.6%
vs SPY	-14.8%	-20.5%	-34.9%	-14.0%	-62.7%

Key facts CIK 1533998 CUSIP 23725P308 Visit website Investor relations

DRIO · DarioHealth Corp.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance